MolNFT v1 · #442710 · protein

AlphaFold monomer V2.0 prediction for neuropathy target esterase sws (B3MRI9)

B3MRI9: “AlphaFold monomer V2.0 prediction for neuropathy target esterase sws (B3MRI9)”. 20 pockets (best druggability 0.79). MolNFT v1 #442710 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession: B3MRI9
Type: protein
Length: 1,514 residues
Chains: 1
Collection: MolNFT v1 / AlphaFold
Contract: 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner: 0xD8Be002F098D25C4405f8f494Dc76De6A4A98A0d
Molecule: Neuropathy target esterase sws
UniProt: B3MRI9
Pockets: 20 · best druggability 0.79

Structure

1 distinct chain · 34% helix, 14% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Neuropathy target esterase sws	protein	1514	34% helix, 14% strand	B3MRI9

Pockets

20 pockets found on a 1 Å grid, 9 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	1046	0.79	0.81	82	empty
2	128	0.78	0.96	26	empty
3	511	0.71	0.81	69	empty
4	429	0.71	0.82	44	empty
5	53	0.63	0.93	13	empty

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt B3MRI9
Elsewhere: UniProt B3MRI9 · AlphaFold DB B3MRI9

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.